High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Aylin Mohammadzadehmarandi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Countercurrent Distribution. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 3M.
Abstract (Originalsprache)
The transition to continuous biomanufacturing has led to renewed interest in alternative approaches for downstream processing of monoclonal antibody (mAb) products. In this study, we examined the potential of using high‐performance countercurrent membrane purification (HPCMP) for the removal of host cell proteins (HCPs) derived from Chinese Hamster Ovary cells in the purification of a mAb. Initial studies used several model proteins to identify appropriate operating conditions for the hollow fiber membrane modules. HPCMP was then used for mAb purification, with mAb yield >95% and more than 100‐fold reduction in HCP. Stable operation was maintained for 48 h for feeds that were first prefiltered through the 3M TM Harvest RC chromatographic clarifier to remove DNA and other foulants. In addition, the Process Mass Intensity for HPCMP can be much less than that for alternative HCP separation processes. These results highlight the potential of using HPCMP as part of a fully continuous mAb production process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
- 3M Separation and Purification Sciences, St. Paul, Minnesota, USA.
- 3M Corporate Research Process Lab, St. Paul, Minnesota, USA.
ORCID-Profile: Andrew L Zydney
Förderung
- 3M
Zitieren
APA
Mohammadzadehmarandi, A., Determan, A., Krumm, C., McIntosh, L. D., & Zydney, A. L. (2023). High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28531
Vancouver
Mohammadzadehmarandi A, Determan A, Krumm C, McIntosh LD, Zydney AL. High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28531
BibTeX
@article{Mohammadzadehmarandi2023,
author = {Mohammadzadehmarandi, Aylin and Determan, Amy and Krumm, Christian and McIntosh, Lucas D and Zydney, Andrew L},
title = {High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28531}
}
EUVIMED